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Congenital/infant acute myeloid leukemia (AML) has poor outcome despite aggressive therapy with 
rare instances of spontaneous remission. The two well-known entities with spontaneous remission 
are transient myeloproliferative disorder (TMD) seen in Down syndrome (DS) newborns and infant 
AML with t(8;16)(p11;p13). While most TMD cases resolve spontaneously, 20-30% would present 
with AML later. 1 Leukemia cutis is common in spontaneously regressing infant AML with 
t(8;16)(p11;p13); among 7 infants reported, 4 relapsed with a median of 17 months.2-4 Here we 
report a congenital AML case with t(1;11)(p32;q23) involving the MLL gene with sustained 
spontaneous remission.  
 
A 2-month old female with an uneventful prenatal history presented with skin lesions first 
seen at 1-month of age (Figure 1A). There were fading skin lesions, otherwise physical exam 
was unremarkable. Complete blood count (CBC) and LDH were within normal limits. Skin 
biopsy revealed CD4 and CD56-positive and myeloperoxidase-negative infiltrating 
monotonous cells with irregular folded and indented nuclei.  Bone marrow morphology and 
flow cytometry findings were consistent with AML (Figure 1B and 1C).  Cytogenetic study 
revealed t(1;11)(p32;q23); FISH analysis showed MLL gene rearrangement, which was 
negative in the peripheral blood. Cerebrospinal fluid analysis was negative for leukemia 
cells. Positron emission tomography did not indicate extramedullary site involvement. 
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Due to already regressing skin lesions, normal CBC, absence of clinical findings and unusual flow 
cytometric findings and following discussions with her parents, a decision for close monitoring was 
made. She achieved remission by morphology, cytogenetic and flow cytometric studies in six weeks 
(Figure1D). Her skin lesions completely resolved and natural killer lymphocytes decreased to normal 
range. She continues to be in complete remission two years from diagnosis.  
 
Eight percent of congenital AML many with monocytic phenotype undergo spontaneous complete 
remission. 4 While AML with the t(1;11)(q21;q23) has 100% overall survival rate in childhood, the 
prognosis of t(1;11)(p32;q23) AML was dismal with a median survival of 15 months. Thirty eight 
percent of reported leukemia patients with t(1;11)(p32;q23) were  infants equally distributed 
between acute lymphoblastic leukemia (ALL) and AML.5,6 This translocation was also seen in 
monozygotic twins with ALL and therapy-related ALL.7,8 No cases of spontaneously resolving 
leukemia with t(1;11)(p32;q23) have been reported.  
 
Leukemia cutis is noted frequently at the onset of disease; rare cases preceding diagnosis were 
reported, likely at the aleukemic phase.9,10 Skin involvement was reported in congenital AML with 
t(1;11)(p32;q23).11 In our case, initial bone marrow involvement pattern was reminiscent of a 
metastatic disease; whether leukemic process started in the skin remains unknown. Leukemia cell 
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Our patient with unique features of leukemia cutis, normal CBC, bone marrow infiltration pattern, 
lack of CD45-dim clonal cells with maturation in abnormal cells, presence of t(1;11)(p32;q23) with 
MLL gene rearrangement and the achievement of sustained spontaneous remission raises the 
possibility of similar cases achieving spontaneous remission that might go unrecognized, with or 
without resurgence of AML. Further molecular analysis would potentially shed light on the 
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Figure Legend: 1A. Raised skin lesions were red/purple in color and spread over time, then 
started to fade slowly leaving mild hyperpigmentation behind. 1B. Bone marrow 
aspiration showed patchy infiltration with immature large cells making up to 12% of 
the cellularity, despite overall well-preserved tri-lineage hematopoiesis with 
increased megakaryocytes and absent dysplastic changes. Abnormal cells had bean-
shaped and folded nuclei and 2-3 nucleoli resembling immature monocytic cells 
accompanied by several mitotic and apoptotic figures. In addition to the occasional 
immature cells among the normal marrow elements, there were sheets of immature 
monocytic cells on the aspirate constituting as high as 85% of cellularity in the 
respective areas. 1C. Flow cytometric analysis did not reveal a distinct CD45-
dim/negative clonal leukemia population on side scatter/CD45 histogram; however, 
gating on the wider monocyte population showed a subpopulation of immature cells 
that were largely myeloperoxidase-negative, similar to what was observed in the 
leukemia cells that infiltrated the skin. Abnormal monocytic cells expressed CD4 and 
partial CD14 and CD56, but were largely negative for CD123. 1D. Six weeks from her 
presentation, bone marrow flow cytometric study showed maturation of these 
immature monocytic cells with increasing expression of CD14 and loss of CD56 
expression. 
 
 
 
